Developmental Therapeutics Core

    Equipment/facility: Facility

      Description

      The Developmental Therapeutics Core (DTC) provides a range of preclinical testing services that include: in vitro tumor cell assays; in vivo subcutaneous and orthotopic models for studying tumor growth, as well as for studying tumor response to therapy; exploratory pharmacokinetics; and exploratory toxicology. The DTC also assists investigators with drug formulations and initial assessments of drug stability. A patient-derived xenograft (PDX) repository provides investigators with more than 60 tumor models representing 12 different types of cancer for in vivo testing of therapies against human tumors. The DTC also maintains a repository with more than 200 human tumor cell lines, many of which can also be used for xenograft establishment and therapeutic testing.

      Fingerprint

      Neoplasms
      Heterografts
      Therapeutics
      Research Personnel
      Drug Stability
      Drug Compounding
      Tumor Cell Line
      Toxicology
      Pharmacokinetics
      Growth
      In Vitro Techniques